Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides. (Q50934997)
Jump to navigation
Jump to search
scientific article published on 2 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides. |
scientific article published on 2 October 2012 |
Statements
1 reference
Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Paola Filipazzi
1 reference
Lorenzo Pilla
1 reference
Agata Cova
1 reference
Gianluigi Rigamonti
1 reference
Felicetta Giardino
1 reference
Annabella Di Florio
1 reference
Marco Asioli
1 reference
Paola Frati
1 reference
Gloria Sovena
1 reference
Paola Squarcina
1 reference
Vanna Chiarion-Sileni
1 reference
Antonello Villa
1 reference
Claudia Lombardo
1 reference
Gabrina Tragni
1 reference
Giorgio Parmiani
1 reference
2 October 2012
1 reference
18
1 reference
6485-6496
1 reference
23
1 reference
Identifiers
1 reference